https://scholars.lib.ntu.edu.tw/handle/123456789/544403
標題: | Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma | 作者: | Wu C.-C. Su C.-T. Lee H.-L. Chung C.-J. CHAO-YUAN HUANG YEONG-SHIAU PU Lin P. Hsueh Y.-M. |
公開日期: | 2012 | 卷: | 188 | 期: | 5 | 起(迄)頁: | 1701-1705 | 來源出版物: | Journal of Urology | 摘要: | Purpose: Cigarette smoking interacts with the urinary arsenic profile to modify the risk of urothelial carcinoma. NNK (4-[methylnitrosamino]-1-[3- pyridyl]-1-butanone) and its metabolite NNAL (4-[methylnitrosamino]-1-[3- pyridyl]-1-butanol) are biomarkers for cigarette smoking exposure. We explored the joint effects of urinary NNK metabolites and arsenic species on urothelial carcinoma risk. Materials and Methods: We recruited 137 pairs of urothelial carcinoma cases and matched healthy participants for a hospital based case-control study. Participants completed questionnaires and provided 50 ml urine samples. Urine samples were analyzed for free NNAL and NNAL-glucuronides using liquid chromatography-tandem mass spectrometry. Samples were analyzed for arsenic species using high performance liquid chromatography hydride generator atomic absorption spectrometry. Results: Overall, subjects with high urinary total NNAL and high total arsenic had a greater urothelial carcinoma risk than those with a low total NNAL and low total arsenic. Subjects with a lower ratio of NNAL-glucuronides-to-free NNAL and higher total arsenic had a greater urothelial carcinoma risk than those with a higher NNAL-glucuronides-to-free NNAL ratio and lower total arsenic. Conclusions: This is the first study to our knowledge to demonstrate a significant trend of progressively increased risk of urothelial carcinoma in subjects who had none, one or both of the factors of urinary total arsenic and total NNAL or urinary total arsenic and the ratio of NNAL-glucuronides-to-free NNAL. ? 2012 American Urological Association Education and Research, Inc. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867401164&doi=10.1016%2fj.juro.2012.07.025&partnerID=40&md5=59f94b89a36e5337807c6966b2cbb882 https://scholars.lib.ntu.edu.tw/handle/123456789/544403 |
ISSN: | 0022-5347 | DOI: | 10.1016/j.juro.2012.07.025 | SDG/關鍵字: | (4 [methylnitrosamino] 1 [3 pyridyl] 1 butanol); arsenic; butanol; glucuronide; unclassified drug; article; atomic absorption spectrometry; cancer risk; controlled study; dose response; educational status; human; liquid chromatography; major clinical study; methylation; priority journal; smoking; tandem mass spectrometry; transitional cell carcinoma; urinalysis; Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; Humans; Methylation; Nitrosamines; Pyridines; Risk; Smoking; Urologic Neoplasms |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。